Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,341 | 72 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $609.98 | 17 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $534.44 | 14 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $443.89 | 12 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $328.86 | 6 | $0 (2022) |
| La Jolla Pharmaceutical Company | $235.65 | 3 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $170.14 | 6 | $0 (2021) |
| Inari Medical, Inc. | $167.68 | 1 | $0 (2022) |
| Chiesi USA, Inc. | $121.13 | 2 | $0 (2022) |
| Mallinckrodt LLC | $120.47 | 1 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $99.39 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $97.76 | 1 | CSL Behring ($97.76) |
| 2022 | $953.53 | 13 | AstraZeneca Pharmaceuticals LP ($329.92) |
| 2021 | $337.59 | 16 | Alexion Pharmaceuticals, Inc. ($136.51) |
| 2020 | $423.18 | 15 | E.R. Squibb & Sons, L.L.C. ($97.15) |
| 2019 | $729.66 | 14 | La Jolla Pharmaceutical Company ($157.09) |
| 2018 | $321.91 | 7 | Janssen Pharmaceuticals, Inc ($107.15) |
| 2017 | $477.12 | 6 | Janssen Pharmaceuticals, Inc ($123.29) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/13/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $97.76 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 11/10/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $109.55 | General |
| Category: Rare Disease | ||||||
| 10/13/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $97.91 | General |
| Category: Rare Disease | ||||||
| 09/28/2022 | Alexion Pharmaceuticals, Inc. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: Rare Disease | ||||||
| 09/08/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $55.92 | General |
| Category: Cardiovascular | ||||||
| 08/11/2022 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $167.68 | General |
| Category: VTE | ||||||
| 08/06/2022 | Alexion Pharmaceuticals, Inc. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Rare Disease | ||||||
| 07/14/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $109.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/12/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $60.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/11/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/10/2022 | Alexion Pharmaceuticals, Inc. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: Rare Disease | ||||||
| 04/18/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/14/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $112.18 | General |
| Category: Rare Disease | ||||||
| 03/10/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $108.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/22/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2021 | Alexion Pharmaceuticals, Inc. | Andexxa (Drug) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: Hematology | ||||||
| 10/06/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Gastroenterology | ||||||
| 09/16/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/12/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/22/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/08/2021 | Alexion Pharmaceuticals, Inc. | Andexxa (Drug) | Food and Beverage | In-kind items and services | $108.23 | General |
| Category: Hematology | ||||||
| 06/25/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.62 | General |
| Category: Cardiovascular | ||||||
| 06/23/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Gastroenterology | ||||||
| 06/23/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/15/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.99 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 159 | 160 | $159,110 | $13,745 |
| 2022 | 5 | 546 | 566 | $518,456 | $47,528 |
| 2021 | 5 | 520 | 538 | $502,948 | $49,744 |
| 2020 | 5 | 571 | 591 | $521,606 | $54,215 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 59 | 60 | $89,880 | $8,093 | 9.0% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 38 | 38 | $38,874 | $3,246 | 8.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 14 | $26,516 | $2,136 | 8.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 48 | 48 | $3,840 | $270.34 | 7.0% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 175 | 180 | $262,204 | $24,494 | 9.3% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 104 | 109 | $108,507 | $10,171 | 9.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 45 | 45 | $82,920 | $7,474 | 9.0% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 79 | 81 | $53,013 | $4,443 | 8.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 143 | 151 | $11,812 | $945.03 | 8.0% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 184 | 188 | $265,474 | $26,668 | 10.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 98 | 107 | $101,508 | $10,157 | 10.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 50 | 50 | $89,466 | $8,826 | 9.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 53 | 57 | $36,146 | $3,229 | 8.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 135 | 136 | $10,354 | $865.83 | 8.4% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 207 | 214 | $287,934 | $30,694 | 10.7% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 104 | 111 | $100,011 | $10,412 | 10.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 42 | 42 | $71,400 | $7,785 | 10.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 83 | 86 | $51,773 | $4,414 | 8.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 135 | 138 | $10,488 | $910.57 | 8.7% |
About Dr. Kristopher Hart, D.O
Dr. Kristopher Hart, D.O is a Emergency Medical Services healthcare provider based in Shawnee, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992800585.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kristopher Hart, D.O has received a total of $3,341 in payments from pharmaceutical and medical device companies, with $97.76 received in 2023. These payments were reported across 72 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,341).
As a Medicare-enrolled provider, Hart has provided services to 1,796 Medicare beneficiaries, totaling 1,855 services with total Medicare billing of $165,233. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Emergency Medical Services
- Other Specialties Emergency Medicine
- Location Shawnee, OK
- Active Since 09/14/2006
- Last Updated 03/05/2025
- Taxonomy Code 207PE0004X
- Entity Type Individual
- NPI Number 1992800585
Products in Payments
- XARELTO (Drug) $534.44
- ELIQUIS (Drug) $491.64
- LOKELMA (Drug) $388.25
- ANDEXXA (Biological) $341.56
- RELISTOR (Drug) $170.14
- FLOWTRIEVER CATHETER, S (Device) $167.68
- Andexxa (Drug) $136.51
- GIAPREZA (Drug) $121.69
- CLEVIPREX (Drug) $121.13
- OFIRMEV (Drug) $120.47
- XIFAXAN (Drug) $99.39
- ULTOMIRIS (Biological) $97.91
- Kcentra (Biological) $97.76
- Orbactiv (Drug) $92.63
- CROFAB (Drug) $89.32
- Veltassa (Drug) $63.25
- X-Porte Ultrasound System (Device) $32.31
- MINOCIN IV (Drug) $12.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.